What technology area does this patent fall under?

Primary CPC classification A01K67/0278. Mapped technology areas include Human Necessities.

When was this patent published?

Publication date Tue Oct 13 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.

What related patents are in patentsdb?

We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).

Humanized IL-15 animals

US9155290B2 · US · B2

Patent metadata
Field	Value
Publication number	US-9155290-B2
Application number	US-201414514454-A
Country	US
Kind code	B2
Filing date	Oct 15, 2014
Priority date	Oct 15, 2013
Publication date	Oct 13, 2015
Grant date	Oct 13, 2015

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

Title
What the patent document calls the invention.
Abstract
A short plain-language summary of the technical disclosure.
Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
Key dates
Filing, priority, publication, and grant dates set the timeline.
First independent claim
The legal scope of protection — read this for what is actually claimed.
CPC / IPC classifications
Technology tags used to group this patent with similar filings.
Citations and related patents
Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Genetically modified non-human animals comprising a humanized interleukin-15 (IL-15) gene. Cells, embryos, and non-human animals comprising a human IL-15 gene. Rodents that express humanized or human IL-15 protein.

First claim

Opening claim text (preview).

What is claimed is: 1. A genetically modified mouse whose genome comprises a replacement at an endogenous mouse IL-15 locus of a mouse genomic segment comprising sequences of mouse exons 3, 4, 5 and 6 coding for a mature mouse IL-15 polypeptide with a human genomic segment comprising human IL-15 exons coding for a mature human IL-15 polypeptide to form a humanized IL-15 gene, wherein the human IL-15 exons in said human genomic segment consist of human exons 3, 4, 5 and 6, wherein…

Assignees

Regeneron Pharma

Inventors

Classifications

A01K2217/07
Human Necessities · mapped topic
C07K14/5443
Chemistry & Metallurgy · mapped topic
A01K67/0278Primary
Human Necessities · mapped topic
A01K2227/10
Human Necessities · mapped topic
A01K2267/0387
Human Necessities · mapped topic

Patent family

Related publications grouped by family.

View patent family 51830649

External sources

Next steps

Free tools are coming soon. Tell us what you want to track and we'll notify you.

Get alerts for this patent View on Google Patents

Request deeper analysis

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9155290B2 cover?: Genetically modified non-human animals comprising a humanized interleukin-15 (IL-15) gene. Cells, embryos, and non-human animals comprising a human IL-15 gene. Rodents that express humanized or human IL-15 protein.
Who is the assignee on this patent?: Regeneron Pharma
What technology area does this patent fall under?: Primary CPC classification A01K67/0278. Mapped technology areas include Human Necessities.
When was this patent published?: Publication date Tue Oct 13 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?: We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).